Report

Enteral Collagen Peptide Protein Market By Form (Powder, Liquid); By Age Group (Adults (Above 18), Pediatrics (Below 18)); By End-User (Hospitals & Clinics, Homecare, Nursing Home); By Region (North America, Europe, Asia Pacific, Middle East & Africa (Mea), South America) : Global Opportunity Analysis And Industry Forecast 2021-2027

  • Publish Date: Apr,2022
  • Report ID: QI040
  • Page : 200
  • Report Type : PDF (Email)
In 2020, the market of global enteral collagen peptide protein value was more than USD 13,586 thousand. The global enteral collagen peptide protein market is forecast to grow at a compound annual growth rate (CAGR) of more than 6% during the forecast period from 2021-2027.

Proteins derived from animal collagen are known as collagen peptide-proteins. Collagen peptide-protein helps provide patients with adequate nutrients whose gastrointestinal function is sufficient for digestion and absorption yet unable to do so orally. During this process, the patient may be unable to eat due to an illness, swallowing difficulties, or complications from surgery that affect their normal eating. This process involves injecting collagen peptides directly into the stomach, duodenum, or jejunum of patients.

Factors Affecting the Market

The rising prevalence of chronic illnesses, like osteoarthritis and heart disease, and the growing demand for collagen peptide protein in the healthcare sector are fueling the global market for enteral collagen peptide protein.
Government initiatives to promote a healthy diet are expected to enhance the opportunities for existing players and new entrants, given the aging population and favorable government initiatives to promote a healthy diet.
The growth of the enteral collagen peptide protein market in underdeveloped countries constrains by inadequate demand and lack of awareness.
The untapped potential of emerging economies anticipates providing new opportunities for the global market to expand.
COVID-19 Impact

The World Health Organization (WHO) considers the COVID-19 outbreak a public health emergency of international concern. The disease has spread to several countries around the world. The adverse effects of COVID-19 on the market for enteral collagen peptide proteins predict a decline in meat consumption, especially fish and bovine products. Consequently, this factor directly affects the production of collagen peptides since fish and beef wastes serve as an essential raw material to produce collagen products. In addition to its negative impact on partnerships and collaborations for enteral collagen peptide protein, the COVID-19 outbreak reduced the production of enteral collagen peptide protein products. As a result of the current global health crisis, the enteral collagen peptide protein market has been negatively affected.

Regional Overview

The enteral collagen peptide protein market in Asia-Pacific offers lucrative opportunities due to the rise in the elderly population, R&D investments in health care products designed to treat various chronic illnesses, and the demand for modern healthcare facilities. In the Asia-Pacific region, the rise in arthritis and leading manufacturers' focus on expanding into emerging markets to capture a large share of the market is forecast to boost the growth of the enteral collagen peptide protein market during the forecast period.

Key Companies

The leading prominent companies in the global enteral collagen peptide protein market are:

Abbott laboratories
Global Health Products, Inc.
Gelita AG
Danone SA (Nutricia)
Medtronic, Inc
Medline Industries, Inc
OP2 labs, LLC
Fresenius Kabi AG
Weishardt Holding SA
Dermarites Industries LLC
Other Prominent Players
Aim of the Report

The global market segmentation of the enteral collagen peptide protein consists of Form, Age Group, End-User, Region.

Segmentation based on Form

Powder
Liquid
Segmentation based on Age Group

Adults (Above 18)
Pediatrics (Below 18)
Segmentation based on End-User

Hospitals & Clinics
Homecare
Nursing Home
Segmentation based on Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America